Isaac Blech

Isaac Blech

Fondatore presso
X-Vax Technology, Inc.
75 anni
Health Technology
Commercial Services
Technology Services

Profilo

Isaac Blech was the founder of Avalo Therapeutics, Inc. (2011), holding the title of Vice Chairman; Sapience Therapeutics, Inc. (2015), holding the title of Vice Chairman; Elucida Oncology, Inc. (2014), holding the title of Vice Chairman.
Mr. Blech is also the founder of Celgene Corp.,PathoGenesis Corp,ICOS Corp.,Nova Pharmaceutical Corp.,Genetic Systems Corp.,X-Vax Technology, Inc.,Nacuity Pharmaceuticals, Inc. Mr. Blech is currently Vice Chairman at Alveo Health LLC, Vice Chairman at Alveo Technologies, Inc., Director at Regenovation, Inc., and Trustee at River Charitable Remainder Unitrust F.
Former positions include Vice Chairman at root9B Holdings, Inc. (2013-2017), Vice Chairman at Edge Therapeutics, Inc., Vice Chairman at Centrexion Therapeutics Corp., Vice Chairman at X4 Pharmaceuticals, Inc., Vice Chairman at Aridis Pharmaceuticals, Inc., Vice Chairman at SpendSmart Networks, Inc. (2011-2020), Vice Chairman at InspireMD, Inc. (2016-2017), Vice Chairman at WaveGuide Corp., Vice Chairman at RestorGenex Corp.
(2013-2016), Vice Chairman at Diffusion Pharmaceuticals, Inc. (2016-2018), Director at Arsanis, Inc., Director at Elicio Therapeutics, Inc. (United States), Independent Director at Aevi Genomic Medicine, Inc. (2011-2017), Independent Director at ContraFect Corp.
(2010-2019), Director at CNS, Inc., Independent Director at Adhera Therapeutics, Inc. (2017-2019), and Director at X4 Pharmaceuticals, Inc. (2015-2019).
Education includes an undergraduate degree from Baruch College, conferred in 1975.

Posizioni attive di Isaac Blech

SocietàPosizioneInizio
River Charitable Remainder Unitrust F/B/O Isaac Blech
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Fondatore 01/01/2015
Direttore/Membro del Consiglio -

Precedenti posizioni note di Isaac Blech

SocietàPosizioneFine
SPENDSMART NETWORKS, INC. Direttore/Membro del Consiglio 14/08/2020
ADHERA THERAPEUTICS, INC. Direttore/Membro del Consiglio 19/12/2019
X4 PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 17/06/2019
CONTRAFECT CORPORATION Direttore/Membro del Consiglio 22/05/2019
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Isaac Blech

Formazione di Isaac Blech

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

51

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private32

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

River Charitable Remainder Unitrust F/B/O Isaac Blech

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Nova Pharmaceutical Corp.

Health Technology

Genetic Systems Corp.

Commercial Services

Miscellaneous

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Isaac Blech